Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Study of Outcomes of Radiofrequency Ablation of Lung Tumors

NCT00280189 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT00280189
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00280189 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Study of Outcomes of Radiofrequency Ablation of Lung Tumors
Lead sponsor
University of Pittsburgh
Phase
Observational
Overall status
Suspended
Start date
September 30, 2003
Completion date
March 31, 2028
Enrollment
72 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nsclc, pulmonary metastases